Mortality and time to extubation in severe hospital-acquired pneumonia.

[1]  C. Glen Mayhall,et al.  Hospital Epidemiology and Infection Control , 2011 .

[2]  Y. Carmeli,et al.  Reference Group Choice and Antibiotic Resistance Outcomes , 2004, Emerging infectious diseases.

[3]  P Gastmeier,et al.  Surveillance of nosocomial infections , 2004 .

[4]  J. Fagon.  Hospital-acquired pneumonia: diagnostic strategies: lessons from clinical trials. , 2003, Infectious disease clinics of North America.

[5]  R. Wunderink,et al.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. , 2003, Chest.

[6]  Victoria J. Fraser,et al.  Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* , 2003, Critical care medicine.

[7]  Jordi Rello,et al.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.

[8]  Marin H Kollef,et al.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.

[9]  T. Similowski,et al.  Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia , 2000, Annals of Internal Medicine.

[10]  D. Cook,et al.  The Clinical Utility of Invasive Diagnostic Techniques in the Setting of Ventilator-Associated Pneumonia* , 1999 .

[11]  M. Niederman,et al.  Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. , 1997, Chest.

[12]  A. Vuagnat,et al.  Nosocomial pneumonia and mortality among patients in intensive care units , 1996 .

[13]  M. Kollef.  Ventilator-Associated Pneumonia , 2005 .

[14]  R. Farinotti,et al.  Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients , 1993, Antimicrobial Agents and Chemotherapy.

[15]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[16]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[17]  R. Wunderink,et al.  Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni , 2003 .

[18]  Incidence of Ventilator-associated Pneumonia , 2022 .